Diana Borgas assists the Biotechnology Group in patent prosecution in the areas of molecular and cellular biology, genetics, biochemistry, and physiology. She has extensive knowledge in the areas of oncology, signal transduction, transgenic technology, mouse disease models, and mammalian tissue culture.
Prior to joining the firm, Diana conducted postdoctoral research in the Department of Medicine at the Warren Alpert Medical School of Brown University in Providence, RI. She investigated the mechanisms by which cigarette smoke induces endothelial cell permeability and contributes to the development of acute lung injury using in vitro and in vivo approaches.
As a graduate student in the Department of Molecular Pharmacology and Physiology at Brown University, Diana investigated the molecular mechanisms that contribute to the dysregulation of cell migration in the contexts of hepatocellular carcinoma and alcoholic liver disease. Her graduate work resulted in presentations at national conferences, merit-based awards, and publications in scientific journals.
Diana’s undergraduate research at Rhode Island College focused on identifying Vibrio species of bacteria that synthesized biodegradable storage material for its potential use in industrial and medical applications.
Diana has written on the topics of alcoholic liver disease, liver cancer, and acute lung injury in various scientific journals, including the Journal of Gastroenterology and Hepatology and the American Journal of Respiratory Cell and Molecular Biology.